美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Frazier Life Sciences Acquisition II (Stock-Only)

10.30

+0.03000.29%

成交量：2.00萬

成交額：20.59萬

市值：9,965.25萬

市盈率：- -

高：10.32

開：10.30

低：10.27

收：10.27

52周最高：10.63

52周最低：10.18

股本：967.50萬

流通股本：700.00萬

量比：0.30

換手率：0.29%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Frazier Life Sciences Acquisition II (Stock-Only)

交易所：

NASDAQ

成立時間：

2026

員工人數：

- -

公司地址：

1001 Page Mill Road,Building 4, Suite 200B,Palo Alto,California,United States

官網：

- -

郵編：

94304

電話：

傳真：

- -

簡介：

Frazier Life Sciences Acquisition Corp. II是一家新組建的空白支票公司，於2026年8月7日註冊成立，為開曼群島豁免有限責任公司，目的是與一個或多個企業或實體進行合併、兼并、股份交換、資產收購、股份購買、重組或類似業務合併。

董事

名稱

職位

Albert Cha

Chief Executive Officer and Director

Benjamin L. Palleiko

Chairman of the Board and Director

R. Scott Struthers

Director

William C. Fairey, Jr.

Director

股東

名稱

職位

Albert Cha

Chief Executive Officer and Director

Fran Adams

Chief Financial Officer

Ali Jackson

General Counsel

Kevin Li

Chief Business Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/FLSC/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FLSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLSC\",,,,,undefined,":{"symbol":"FLSC","market":"US","secType":"STK","nameCN":"Frazier Life Sciences Acquisition II (Stock-Only)","latestPrice":10.3,"timestamp":1792785600000,"preClose":10.27,"halted":0,"volume":20001,"delay":0,"changeRate":0.0029211295034080953,"floatShares":7000000,"shares":9675000,"eps":0,"marketStatus":"盤後交易","change":0.03,"latestTime":"10-23 18:36:00 EDT","open":10.3,"high":10.32,"low":10.265,"amount":205935,"amplitude":0.005355,"askPrice":11.24,"askSize":100,"bidPrice":9.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1792800000000},"marketStatusCode":4,"adr":0,"listingDate":1791950400000,"exchange":"NASDAQ","adjPreClose":10.27,"volumeRatio":0.295027},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLSC\",,,,,undefined,":{"symbol":"FLSC","floatShares":7000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.295027,"shares":9675000,"dividePrice":0,"high":10.32,"amplitude":0.005355,"preClose":10.27,"low":10.265,"week52Low":10.18,"pbRate":"--","week52High":10.625,"institutionHeld":0,"latestPrice":10.3,"eps":0,"divideRate":0,"volume":20001,"delay":0,"ttmEps":0,"open":10.3,"prevYearClose":10.18,"prevWeekClose":10.35,"prevMonthClose":10.18,"prevQuarterClose":10.18,"fiveDayClose":10.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FLSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FLSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FLSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2021015746,"yearFounded":2026,"address":"1001 Page Mill Road,Building 4, Suite 200B,Palo Alto,California,United States","zipCode":"94304","officePhone":"650 325 5156"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.021},{"period":"1month","weight":0.0088},{"period":"ytd","weight":0.0088}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.144},{"period":"ytd","weight":0.1203}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Frazier Life Sciences Acquisition Corp. II是一家新組建的空白支票公司，於2026年8月7日註冊成立，為開曼群島豁免有限責任公司，目的是與一個或多個企業或實體進行合併、兼并、股份交換、資產收購、股份購買、重組或類似業務合併。","exchange":"NASDAQ","name":"Frazier Life Sciences Acquisition II (Stock-Only)","nameEN":"Frazier Life Sciences Acquisition II (Stock-Only)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FLSC\",market:\"US\",,,undefined,":{"directors":[{"name":"Albert Cha","position":"Chief Executive Officer and Director"},{"name":"Benjamin L. Palleiko","position":"Chairman of the Board and Director"},{"name":"R. Scott Struthers","position":"Director"},{"name":"William C. Fairey, Jr.","position":"Director"}],"executives":[{"name":"Albert Cha","position":"Chief Executive Officer and Director"},{"name":"Fran Adams","position":"Chief Financial Officer"},{"name":"Ali Jackson","position":"General Counsel"},{"name":"Kevin Li","position":"Chief Business Officer"}]}}}